| UniProt ID | TM201_HUMAN | |
|---|---|---|
| UniProt AC | Q5SNT2 | |
| Protein Name | Transmembrane protein 201 | |
| Gene Name | TMEM201 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 666 | |
| Subcellular Localization |
Isoform 2: Nucleus inner membrane Multi-pass membrane protein . Cytoplasm, cytoskeleton, spindle pole . The C-terminal of isoform 2 is located on the nucleoplasmic side. During interphase, isoform 2 is distributed in the inner nuclear membrane in d |
|
| Protein Description | Involved in nuclear movement during fibroblast polarization and migration. Proposed to be involved in actin-dependent nuclear movement via association with transmembrane actin-associated nuclear (TAN) lines which are bound to F-actin cables and couple the nucleus to retrograde actin flow (By similarity). Overexpression can recruit Ran GTPase to the nuclear periphery. [PubMed: 27541860; Isoform 2: May define a distinct membrane domain in the vicinity of the mitotic spindle] | |
| Protein Sequence | MEGVSALLARCPTAGLAGGLGVTACAAAGVLLYRIARRMKPTHTMVNCWFCNQDTLVPYGNRNCWDCPHCEQYNGFQENGDYNKPIPAQYLEHLNHVVSSAPSLRDPSQPQQWVSSQVLLCKRCNHHQTTKIKQLAAFAPREEGRYDEEVEVYRHHLEQMYKLCRPCQAAVEYYIKHQNRQLRALLLSHQFKRREADQTHAQNFSSAVKSPVQVILLRALAFLACAFLLTTALYGASGHFAPGTTVPLALPPGGNGSATPDNGTTPGAEGWRQLLGLLPEHMAEKLCEAWAFGQSHQTGVVALGLLTCLLAMLLAGRIRLRRIDAFCTCLWALLLGLHLAEQHLQAASPSWLDTLKFSTTSLCCLVGFTAAVATRKATGPRRFRPRRFFPGDSAGLFPTSPSLAIPHPSVGGSPASLFIPSPPSFLPLANQQLFRSPRRTSPSSLPGRLSRALSLGTIPSLTRADSGYLFSGSRPPSQVSRSGEFPVSDYFSLLSGSCPSSPLPSPAPSVAGSVASSSGSLRHRRPLISPARLNLKGQKLLLFPSPPGEAPTTPSSSDEHSPHNGSLFTMEPPHVPRKPPLQDVKHALDLRSKLERGSACSNRSIKKEDDSSQSSTCVVDTTTRGCSEEAATWRGRFGPSLVRGLLAVSLAANALFTSVFLYQSLR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEGVSALL -------CCCHHHHH | 10.24 | 22814378 | |
| 5 | Phosphorylation | ---MEGVSALLARCP ---CCCHHHHHHHCC | 24.85 | 20068231 | |
| 40 | Ubiquitination | YRIARRMKPTHTMVN HHHHHHCCCCEEEEE | 44.98 | - | |
| 82 | Phosphorylation | GFQENGDYNKPIPAQ CCCCCCCCCCCCCHH | 26.87 | 22817900 | |
| 93 | Ubiquitination | IPAQYLEHLNHVVSS CCHHHHHHHHCHHHC | 29.36 | 22817900 | |
| 95 | Ubiquitination | AQYLEHLNHVVSSAP HHHHHHHHCHHHCCC | 28.02 | 21890473 | |
| 131 | Ubiquitination | CNHHQTTKIKQLAAF CCCCCCHHHHHHHHH | 51.82 | 22817900 | |
| 133 (in isoform 2) | Ubiquitination | - | 40.59 | 21890473 | |
| 133 (in isoform 1) | Ubiquitination | - | 40.59 | 21890473 | |
| 133 | Ubiquitination | HHQTTKIKQLAAFAP CCCCHHHHHHHHHCC | 40.59 | 27667366 | |
| 146 | Phosphorylation | APREEGRYDEEVEVY CCCCCCCCCHHHHHH | 38.27 | 19060867 | |
| 153 | Phosphorylation | YDEEVEVYRHHLEQM CCHHHHHHHHHHHHH | 7.25 | 19060867 | |
| 154 | Ubiquitination | DEEVEVYRHHLEQMY CHHHHHHHHHHHHHH | 18.87 | 21890473 | |
| 161 | Phosphorylation | RHHLEQMYKLCRPCQ HHHHHHHHHHHHHHH | 10.66 | 17693683 | |
| 173 | Phosphorylation | PCQAAVEYYIKHQNR HHHHHHHHHHHHHHH | 12.14 | 28152594 | |
| 174 | Phosphorylation | CQAAVEYYIKHQNRQ HHHHHHHHHHHHHHH | 7.03 | 28152594 | |
| 188 | Phosphorylation | QLRALLLSHQFKRRE HHHHHHHHHHHHHHH | 18.40 | 21712546 | |
| 192 (in isoform 2) | Ubiquitination | - | 43.93 | 21890473 | |
| 192 | Ubiquitination | LLLSHQFKRREADQT HHHHHHHHHHHHHHH | 43.93 | 22817900 | |
| 192 (in isoform 1) | Ubiquitination | - | 43.93 | 21890473 | |
| 192 | 2-Hydroxyisobutyrylation | LLLSHQFKRREADQT HHHHHHHHHHHHHHH | 43.93 | - | |
| 416 | Phosphorylation | SVGGSPASLFIPSPP CCCCCCHHHCCCCCC | 27.48 | - | |
| 440 | Phosphorylation | LFRSPRRTSPSSLPG HHCCCCCCCCCCCCC | 46.39 | 30266825 | |
| 441 | Phosphorylation | FRSPRRTSPSSLPGR HCCCCCCCCCCCCCH | 22.45 | 29255136 | |
| 443 | Phosphorylation | SPRRTSPSSLPGRLS CCCCCCCCCCCCHHH | 44.25 | 30266825 | |
| 444 | Phosphorylation | PRRTSPSSLPGRLSR CCCCCCCCCCCHHHH | 41.80 | 30266825 | |
| 450 | Phosphorylation | SSLPGRLSRALSLGT CCCCCHHHHHHHHCC | 17.72 | 26055452 | |
| 454 | Phosphorylation | GRLSRALSLGTIPSL CHHHHHHHHCCCCCC | 24.62 | 29255136 | |
| 457 | Phosphorylation | SRALSLGTIPSLTRA HHHHHHCCCCCCCCC | 34.70 | 30266825 | |
| 460 | Phosphorylation | LSLGTIPSLTRADSG HHHCCCCCCCCCCCC | 38.22 | 23927012 | |
| 462 | Phosphorylation | LGTIPSLTRADSGYL HCCCCCCCCCCCCCC | 28.31 | 23927012 | |
| 466 | Phosphorylation | PSLTRADSGYLFSGS CCCCCCCCCCCCCCC | 28.49 | 23401153 | |
| 468 | Phosphorylation | LTRADSGYLFSGSRP CCCCCCCCCCCCCCC | 14.44 | 30108239 | |
| 471 | Phosphorylation | ADSGYLFSGSRPPSQ CCCCCCCCCCCCHHH | 33.01 | 21955146 | |
| 473 | Phosphorylation | SGYLFSGSRPPSQVS CCCCCCCCCCHHHCC | 40.18 | 21955146 | |
| 477 | Phosphorylation | FSGSRPPSQVSRSGE CCCCCCHHHCCCCCC | 45.99 | 21955146 | |
| 480 | Phosphorylation | SRPPSQVSRSGEFPV CCCHHHCCCCCCCCH | 17.06 | 21955146 | |
| 482 | Phosphorylation | PPSQVSRSGEFPVSD CHHHCCCCCCCCHHH | 34.86 | 24144214 | |
| 488 | Phosphorylation | RSGEFPVSDYFSLLS CCCCCCHHHHHHHHH | 27.16 | 24144214 | |
| 490 | Phosphorylation | GEFPVSDYFSLLSGS CCCCHHHHHHHHHCC | 6.38 | 30576142 | |
| 492 | Phosphorylation | FPVSDYFSLLSGSCP CCHHHHHHHHHCCCC | 23.36 | 24144214 | |
| 495 | Phosphorylation | SDYFSLLSGSCPSSP HHHHHHHHCCCCCCC | 33.67 | 24144214 | |
| 497 | Phosphorylation | YFSLLSGSCPSSPLP HHHHHHCCCCCCCCC | 21.34 | 24144214 | |
| 500 | Phosphorylation | LLSGSCPSSPLPSPA HHHCCCCCCCCCCCC | 49.25 | 24144214 | |
| 501 | Phosphorylation | LSGSCPSSPLPSPAP HHCCCCCCCCCCCCC | 18.65 | 24144214 | |
| 505 | Phosphorylation | CPSSPLPSPAPSVAG CCCCCCCCCCCCCCH | 41.18 | 24144214 | |
| 509 | Phosphorylation | PLPSPAPSVAGSVAS CCCCCCCCCCHHHHC | 27.06 | 24144214 | |
| 513 | Phosphorylation | PAPSVAGSVASSSGS CCCCCCHHHHCCCCC | 12.55 | 24144214 | |
| 516 | Phosphorylation | SVAGSVASSSGSLRH CCCHHHHCCCCCCCC | 23.92 | 24144214 | |
| 517 | Phosphorylation | VAGSVASSSGSLRHR CCHHHHCCCCCCCCC | 29.05 | 30576142 | |
| 518 | Phosphorylation | AGSVASSSGSLRHRR CHHHHCCCCCCCCCC | 29.88 | 24144214 | |
| 520 | Phosphorylation | SVASSSGSLRHRRPL HHHCCCCCCCCCCCC | 24.95 | 30576142 | |
| 529 | Phosphorylation | RHRRPLISPARLNLK CCCCCCCCCEEECCC | 21.86 | 28176443 | |
| 540 | Ubiquitination | LNLKGQKLLLFPSPP ECCCCCEEEECCCCC | 3.74 | 27667366 | |
| 545 | Phosphorylation | QKLLLFPSPPGEAPT CEEEECCCCCCCCCC | 36.07 | 26074081 | |
| 552 | Phosphorylation | SPPGEAPTTPSSSDE CCCCCCCCCCCCCCC | 59.39 | 23401153 | |
| 553 | Phosphorylation | PPGEAPTTPSSSDEH CCCCCCCCCCCCCCC | 21.80 | 26074081 | |
| 554 | Ubiquitination | PGEAPTTPSSSDEHS CCCCCCCCCCCCCCC | 34.39 | 27667366 | |
| 555 | Phosphorylation | GEAPTTPSSSDEHSP CCCCCCCCCCCCCCC | 40.14 | 29116813 | |
| 556 | Phosphorylation | EAPTTPSSSDEHSPH CCCCCCCCCCCCCCC | 42.91 | 29116813 | |
| 557 | Phosphorylation | APTTPSSSDEHSPHN CCCCCCCCCCCCCCC | 51.89 | 29116813 | |
| 561 | Phosphorylation | PSSSDEHSPHNGSLF CCCCCCCCCCCCCCC | 26.30 | 27174698 | |
| 566 | Phosphorylation | EHSPHNGSLFTMEPP CCCCCCCCCCCCCCC | 26.15 | 27174698 | |
| 569 | Phosphorylation | PHNGSLFTMEPPHVP CCCCCCCCCCCCCCC | 26.39 | 27174698 | |
| 578 | Ubiquitination | EPPHVPRKPPLQDVK CCCCCCCCCCHHHHH | 44.94 | 27667366 | |
| 585 | Ubiquitination | KPPLQDVKHALDLRS CCCHHHHHHHHHHHH | 31.30 | 29967540 | |
| 604 | Phosphorylation | GSACSNRSIKKEDDS CCCCCCCCCCCCCCC | 42.90 | 25072903 | |
| 611 | Phosphorylation | SIKKEDDSSQSSTCV CCCCCCCCCCCCEEE | 42.47 | 23663014 | |
| 612 | Phosphorylation | IKKEDDSSQSSTCVV CCCCCCCCCCCEEEE | 40.87 | 23663014 | |
| 614 | Phosphorylation | KEDDSSQSSTCVVDT CCCCCCCCCEEEEEC | 29.57 | 23663014 | |
| 615 | Phosphorylation | EDDSSQSSTCVVDTT CCCCCCCCEEEEECC | 20.42 | 23663014 | |
| 616 | Phosphorylation | DDSSQSSTCVVDTTT CCCCCCCEEEEECCC | 17.99 | 23663014 | |
| 621 | Phosphorylation | SSTCVVDTTTRGCSE CCEEEEECCCCCCCH | 20.61 | 20639409 | |
| 622 | Phosphorylation | STCVVDTTTRGCSEE CEEEEECCCCCCCHH | 15.27 | 20639409 | |
| 623 | Phosphorylation | TCVVDTTTRGCSEEA EEEEECCCCCCCHHH | 27.44 | 20639409 | |
| 627 | Phosphorylation | DTTTRGCSEEAATWR ECCCCCCCHHHHHHC | 41.10 | - | |
| 649 | Phosphorylation | VRGLLAVSLAANALF HHHHHHHHHHHHHHH | 13.49 | 20860994 | |
| 657 | Phosphorylation | LAANALFTSVFLYQS HHHHHHHHHHHHHHH | 25.49 | 20860994 | |
| 658 | Phosphorylation | AANALFTSVFLYQSL HHHHHHHHHHHHHHH | 11.97 | 20860994 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM201_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM201_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM201_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of TM201_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-454, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441; SER-454 ANDSER-529, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-441 AND SER-454, ANDMASS SPECTROMETRY. | |
| "Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-146; TYR-153 ANDTYR-161, AND MASS SPECTROMETRY. | |